Molecular diagnostics corporations Seegene said on the 5th it has established a subsidiary in France. According to market research firm Grand View Research, the French molecular diagnostics market is estimated at 1 trillion won. Seegene plans to introduce products related to gastrointestinal and respiratory diseases and cervical cancer.
The French subsidiary is Seegene's eighth overseas subsidiary. France requires the supply of customized products. Seegene plans to respond to this market structure through the local subsidiary. A Seegene official said, "We will hire experienced professionals to expand the business."
Meanwhile, Seegene's overseas sales account for 93% of the total. Of that, Europe accounts for 63%.
※ This article has been translated by AI. Share your feedback here.